Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Hypertension (Dallas, Tex. : 1979)|December 8, 2004
Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstrictionJoep H M van Esch, Beril Tom, Vincent Dive, et al.
Chemmedchem|July 1, 2016
Sugar-Based Arylsulfonamide Carboxylates as Selective and Water-Soluble Matrix Metalloproteinase-12 InhibitorsElisa Nuti, Doretta Cuffaro, Felicia D'Andrea, et al.
Bioconjugate Chemistry|August 27, 2016
Synthesis and in Vitro and in Vivo Evaluation of MMP-12 Selective Optical ProbesThomas Bordenave, Marion Helle, Fabrice Beau, et al.
Molecular Pharmaceutics|September 23, 2016
Optimization and in Vivo Validation of Peptide Vectors Targeting the LDL ReceptorGuillaume Jacquot, Pascaline Lécorché, Jean-Daniel Malcor, et al.
The Journal of Cell Biology|August 3, 2019
Metalloprotease inhibitor TIMP proteins control FGF-2 bioavailability and regulate skeletal growthSanjay Saw, Alison Aiken, Hui Fang, et al.
Angewandte Chemie (International Ed. in English)|June 7, 2021
Ligand-Directed Modification of Active Matrix Metalloproteases: Activity-based Probes with no Photolabile GroupMonika Kaminska, Pierrick Bruyat, Carole Malgorn, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Bifunctional Inhibitors as a New Tool To Reduce Cancer Cell Invasion by Impairing MMP-9 HomodimerizationElisa Nuti, Lea Rosalia, Doretta Cuffaro, et al.
Journal of Neurochemistry|April 30, 2003
The C-type natriuretic peptide precursor of snake brain contains highly specific inhibitors of the angiotensin-converting enzymeMirian A F Hayashi, Alessandra F Murbach, Danielle Ianzer, et al.
Molecular Metabolism|December 25, 2022
Molecular interactions of PCSK9 with an inhibitory nanobody, CAP1 and HLA-C: Functional regulation of LDLR levelsCarole Fruchart Gaillard, Ali Ben Djoudi Ouadda, Lidia Ciccone, et al.
Pageof 10